IL17A and metabolic dysfunction-associated steatotic liver disease: Obese individuals have higher serum IL-23 and IL-17 levels than non-obese individuals (68–70) and increased IL-17 levels have been found in patients with type 1 and 2 diabetes, non-alcoholic fatty liver disease or steatohepatitis (69).